Homo-oligomerization of the human adenosine A2a receptor is driven by the intrinsically disordered C-terminus

  1. Khanh Dinh Quoc Nguyen
  2. Michael Vigers
  3. Eric Sefah
  4. Susanna Seppälä
  5. Jennifer Paige Hoover
  6. Nicole Star Schonenbach
  7. Blake Mertz
  8. Michelle Ann O'Malley  Is a corresponding author
  9. Songi Han  Is a corresponding author
  1. University of California - Santa Barbaba, United States
  2. West Virginia University, United States
  3. University of California Santa Barbara, United States

Abstract

G protein-coupled receptors (GPCRs) have long been shown to exist as oligomers with functional properties distinct from those of the monomeric counterparts, but the driving factors of oligomerization remain relatively unexplored. Herein, we focus on the human adenosine A2A receptor (A2AR), a model GPCR that forms oligomers both in vitro and in vivo. Combining experimental and computational approaches, we discover that the intrinsically disordered C-terminus of A2AR drives receptor homo-oligomerization. The formation of A2AR oligomers declines progressively with the shortening of the C-terminus. Multiple interaction types are responsible for A2AR oligomerization, including disulfide linkages, hydrogen bonds, electrostatic interactions, and hydrophobic interactions. These interactions are enhanced by depletion interactions, giving rise to a tunable network of bonds that allow A2AR oligomers to adopt multiple interfaces. This study uncovers the disordered C-terminus as a prominent driving factor for the oligomerization of a GPCR, offering important insight into the effect of C-terminus modification on receptor oligomerization of A2AR and other GPCRs reconstituted in vitro for biophysical studies.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Khanh Dinh Quoc Nguyen

    Chemistry and Biochemistry, University of California - Santa Barbaba, Santa Barbara, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9367-499X
  2. Michael Vigers

    Chemistry and Biochemistry, University of California - Santa Barbaba, Santa Barbara, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Eric Sefah

    C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Susanna Seppälä

    Chemical Engineering, University of California - Santa Barbaba, Santa Barbara, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Jennifer Paige Hoover

    Chemistry and Biochemistry, University of California - Santa Barbaba, Santa Barbara, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Nicole Star Schonenbach

    Chemistry and Biochemistry, University of California - Santa Barbaba, Santa Barbara, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Blake Mertz

    C. Eugene Bennett Department of Chemistry, West Virginia University, Morgantown, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Michelle Ann O'Malley

    Chemical Engineering, University of California - Santa Barbaba, Santa Barbara, United States
    For correspondence
    momalley@engineering.ucsb.edu
    Competing interests
    The authors declare that no competing interests exist.
  9. Songi Han

    Department of Chemistry and Biochemistry, Department of Chemical Engineering, University of California Santa Barbara, Santa Barbara, United States
    For correspondence
    songi@chem.ucsb.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6489-6246

Funding

National Institute of General Medical Sciences (R35GM136411)

  • Khanh Dinh Quoc Nguyen
  • Michael Vigers
  • Susanna Seppälä
  • Nicole Star Schonenbach
  • Michelle Ann O'Malley
  • Songi Han

National Institute of Mental Health (Small Business Innovation Research Award,1R43MH119906-01)

  • Khanh Dinh Quoc Nguyen
  • Jennifer Paige Hoover
  • Michelle Ann O'Malley
  • Songi Han

National Science Foundation (MCB-1714888)

  • Eric Sefah
  • Blake Mertz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Nguyen et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,975
    views
  • 327
    downloads
  • 10
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Khanh Dinh Quoc Nguyen
  2. Michael Vigers
  3. Eric Sefah
  4. Susanna Seppälä
  5. Jennifer Paige Hoover
  6. Nicole Star Schonenbach
  7. Blake Mertz
  8. Michelle Ann O'Malley
  9. Songi Han
(2021)
Homo-oligomerization of the human adenosine A2a receptor is driven by the intrinsically disordered C-terminus
eLife 10:e66662.
https://doi.org/10.7554/eLife.66662

Share this article

https://doi.org/10.7554/eLife.66662

Further reading

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Senem Ntourmas, Martin Sachs ... Dominic B Bernkopf
    Research Article

    Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.

    1. Biochemistry and Chemical Biology
    Bikash Adhikari, Katharina Schneider ... Elmar Wolf
    Research Article

    The development of proteolysis targeting chimeras (PROTACs), which induce the degradation of target proteins by bringing them into proximity with cellular E3 ubiquitin ligases, has revolutionized drug development. While the human genome encodes more than 600 different E3 ligases, current PROTACs use only a handful of them, drastically limiting their full potential. Furthermore, many PROTAC development campaigns fail because the selected E3 ligase candidates are unable to induce degradation of the particular target of interest. As more and more ligands for novel E3 ligases are discovered, the chemical effort to identify the best E3 ligase for a given target is exploding. Therefore, a genetic system to identify degradation-causing E3 ligases and suitable target/E3 ligase pairs is urgently needed. Here, we used the well-established dimerization of the FKBP12 protein and FRB domain by rapamycin to bring the target protein WDR5 into proximity with candidate E3 ligases. Strikingly, this rapamycin-induced proximity assay (RiPA) revealed that VHL, but not Cereblon, is able to induce WDR5 degradation - a finding previously made by PROTACs, demonstrating its predictive power. By optimizing the steric arrangement of all components and fusing the target protein with a minimal luciferase, RiPA can identify the ideal E3 for any target protein of interest in living cells, significantly reducing and focusing the chemical effort in the early stages of PROTAC development.